RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles see all

Displaying items 1-5
  • China fines drugmaker GlaxoSmithKline $492 million in bribery case

    China fines drugmaker GlaxoSmithKline $492 million in bribery case
    China on Friday leveled a half-billion-dollar fine against British drugmaker GlaxoSmithKline after an investigation concluded that the company bribed physicians and hospitals to use its products.
  • Former head of GlaxoSmithKline in China is accused of bribery

    The former head of GlaxoSmithKline in China was charged with corruption by local authorities after a probe that resulted in accusations that the drug maker ran a wide-ranging bribery scheme that included payoffs to doctors. Chinese police alleged that...

    Chinese dissident, in TV shaming, apologizes for spilling secrets

    Chinese dissident, in TV shaming, apologizes for spilling secrets
    One of China’s most venerable dissident journalists was paraded  on state television Thursday morning, apologizing for spilling state secrets that embarrassed the Chinese Communist Party. The public shaming of Gao Yu, a 70-year-old grandmother who...

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...